Navigation Links
Trident approach reduces malaria in HIV patients

Researchers at Uganda Virus Research Institute said that combining anti-AIDS drugs, an antibiotic and bed nets treated with insecticide could cut the rate of malaria // infections in people infected with HIV by up to 95 percent. "Our study was able to show that with the implementation of a few interventions the incidence of malaria can be dropped considerably," said Dr Jonathan Mermin, of the Uganda Virus Research Institute in Entebbe, Uganda.

The finding was that antiretroviral drugs, the antibiotic co-trimoxazole and bed nets are each effective in combating malaria in HIV patients but when combined their impact is cumulative.

The impact of individual and combined treatments for malaria in about 1,000 HIV positive people in Uganda was studied by the researchers.

Co-trimoxazole, is a standard treatment worldwide for patients infected with HIV, reduced the incidence of malaria in the patients by 76 percent. When combined with anti-AIDS drugs it hit 92 percent and cut cases by up to 95 percent when the bed nets were included.

"Although these interventions work separately, the prime message is that together they are associated with a 95 percent reduction in malaria. Malaria then becomes a rare event among this population whereas before the interventions it was quite common," said Mermin.

According to WHO more than 40 million people worldwide are living with HIV/AIDS. The majority, more than 25 million, are in sub-Saharan Africa. In 2005 about 2.4 million people in the region died from HIV/AIDS, according to the UNAIDS, which is leading the global battle against the illness.

In this light of statistics this research is a new ray of light for millions of patients.


'"/>




Page: 1

Related medicine news :

1. Fresh approach to TB treatment
2. New approach to anti-anxiety drugs
3. More signs to an approaching migraine attack
4. Gene enchances radiation therapy - A novel approach to fight cancer
5. Combined modality approach for effective treatment and enhanced survival in bile duct cancer
6. A new approach to vaginal hysterectomy
7. Multi targeted approach required for suicide prevention in adolescents
8. Mathematical approach to asthma
9. A Novel approach in Malaria treatment
10. Stress reduces your immunity- startling but true!!!!!
11. Thirty minutes of work up per day reduces the risk of Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2016)... ... 29, 2016 , ... Reltok Nasal Products proudly announces that Boston Medical Products, ... nose and throat specialty, has added the KOTLER NASAL AIRWAY™ to its diverse product ... a newly patented safety device secured by nasal surgeons onto the floor of the ...
(Date:4/29/2016)... ... 29, 2016 , ... Regenerative Medicine Solutions (RMS) scored 94.8124 out ... earning them second place for Tampa’s Best Places to Work. They were ranked in ... a great accomplishment for our team,” says RMS Human Resources Manager Irene Miller. “We ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... promote their animal line of probiotics, Petbiotics ™, as they fondly call ... of animal rescue groups networking for their non-profit organizations. Animal rescues across the ...
(Date:4/29/2016)... ... April 29, 2016 , ... Intellitec Solutions is pleased to ... Dynamics GP for one their long-term care clients. Working together with the clients ... key clinical management systems, and delivered a fully integrated accounting and business-management solution ...
(Date:4/29/2016)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in ... saying it is time to set the record straight. Traditionally, BC and AD has ... possibly be true and offers explanation. , “To start with, the Name of the ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... TapImmune,Inc. (TPIV), a clinical-stage immune-oncology company ... and vaccines for the treatment of cancer & metastatic disease, ... Growth Capital Expo to be held on May 3 ... in Las Vegas, Nevada.  The Company presentation will be ... by Dr. John N. Bonfiglio a TapImmune Board ...
(Date:4/27/2016)... Inc. (Nasdaq: HOLX ) announced today ... quarter ended March 26, 2016.  GAAP diluted earnings ... non-GAAP diluted EPS of $0.47 increased 14.6%.  Revenue ... basis, and 6.3% on a constant currency basis.  ... highlighted by 14.6% growth in non-GAAP EPS," said ...
(Date:4/27/2016)... Avril 2016   ... +5% sur le trimestre, soutenu par une croissance ... Croissance de +16% des ventes aux hôpitaux ... Kea Technologies (Euronext : MKEA, FR0010609263 ; OTCQX : MKEAY), inventeur ... aujourd,hui son chiffre d,affaires pour le premier trimestre ...
Breaking Medicine Technology: